Related Experiment Video
Updated: Jun 17, 2026
11:20
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer
Wilbur A Franklin1, Jerry Haney, Michio Sugita
1Department of Pathology, University of Colorado Denver, Fitzsimons Campus, 12801 E. 17 Ave., Aurora, CO 80045, USA. wilbur.franklin@uchsc.edu
The Journal of Molecular Diagnostics : JMD
|December 17, 2009
Summary
Accurate KRAS mutation testing is crucial for colon cancer treatment. Amplification Refractory Mutation System (ARMS/S) using paraffin cores is a sensitive and specific method for detecting these mutations.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cetuximab treatment for colon carcinoma is ineffective in KRAS-mutant tumors.
- Accurate KRAS mutation detection is essential for effective patient stratification.
- Current mutation testing methods require evaluation for sensitivity and specificity.
Purpose of the Study:
- To compare three KRAS mutation detection methods: high-resolution melting, ARMS/S, and direct sequencing.
- To evaluate the impact of tissue sampling techniques (sectioning vs. coring) on assay performance.
- To identify the most sensitive and specific method for KRAS mutation analysis in colon carcinoma.
Main Methods:
- Compared high-resolution melting, ARMS/S, and direct sequencing for KRAS mutation detection.
- Analyzed 59 colon carcinoma cases using DNA from paraffin-embedded blocks.
- Evaluated DNA extraction from paraffin sections versus 1-mm paraffin cores.
Main Results:
- ARMS/S using 1-mm paraffin cores demonstrated the highest sensitivity and specificity.
- This optimal combination detected KRAS mutations in 46% of colon tumors.
- ARMS/S identified four mutations missed by initial direct sequencing, later confirmed by re-sequencing cloned DNA.
Conclusions:
- Coring paraffin blocks and employing ARMS/S is a highly sensitive, specific, and efficient method for KRAS testing.
- This approach improves the accuracy of identifying KRAS mutations in colon cancer.
- Optimized tissue sampling and molecular testing are critical for personalized cancer therapy.
